FDA formally announced the end of the tirzepatide shortage in a Declaratory Order issued to Eli Lilly & Co. (“Lilly”). Lilly ...

The FDA initially declared the tirzepatide shortage over in October, but the Outsourcing Facilities Association, a trade group for compounding pharmacists, sued, claiming the drug was still in ...

For its part, the Outsourcing Facilities Association said in a report to the court that "Survey data from this month shows increasing numbers of patients unable to obtain branded GLP-1 agonist ...

The suit was filed by the Outsourcing Facilities Association (OFA), a trade group that represents 503B compounding pharmacies, seeking to overturn the FDA’s decision. After the suit was filed ...

As expected by many, Eli Lilly And Co (NYSE:LLY) filed a motion to intervene as a defendant in a case between the Outsourcing Facilities Association and FarmaKeio Custom Compounding against the FDA.

Compounders aren't eager to pack it in. The Outsourcing Facilities Association, another industry group that represents ...

The FDA declined to comment. The Outsourcing Facilities Association, which brought the lawsuit along with a Texas compounding pharmacy did not immediately respond to requests for comment.

following a proposal by the trade group the Outsourcing Facilities Association (OFA) to add the molecule to its compounding roster. Apart from Victoza, which was approved for Type 2 diabetes in ...

In a Citizen Petition posted on Regulations.gov, Novo Nordisk (NVO) noted that the Outsourcing Facilities Association, or OFA, has nominated liraglutide be added to their list of bulk drug ...